Irritable Bowel Syndrome News and Research

Latest Irritable Bowel Syndrome News and Research

Burrill Biotech Select Index manages to claw back almost half the value it lost in October

Burrill Biotech Select Index manages to claw back almost half the value it lost in October

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

MicroDose Therapeutx acquires a portfolio of compounds from Epix Pharmaceuticals

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting

Additional data on lubiprostone presented at the GASTRO 2009 UEGF/WCOG meeting

Top-line data from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS to be presented

Top-line data from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS to be presented

Swissmedic grants marketing authorization for Amitiza

Swissmedic grants marketing authorization for Amitiza

Gastrointestinal symptoms may interfere with nutritional management of ED patients

Gastrointestinal symptoms may interfere with nutritional management of ED patients

Albireo completes A3309 phase 1b study in patients with chronic idiopathic constipation

Albireo completes A3309 phase 1b study in patients with chronic idiopathic constipation

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

PPD, Janssen Pharmaceutica to develop therapeutic compounds for IBS and bacterial infections

Positive results from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS

Positive results from Lexicon Pharmaceuticals' LX1031 Phase 2 study for IBS

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

Astellas receives exclusive rights to develop and commercialize linaclotide compound in Asia

GI and hepatology societies take initiative to evaluate the current medical school curriculum

GI and hepatology societies take initiative to evaluate the current medical school curriculum

Top-line results from Phase 3 linaclotide trial for chronic constipation

Top-line results from Phase 3 linaclotide trial for chronic constipation

SQI Diagnostics' SQiDworks automated platform and IgXPLEX RA assay receive FDA marketing clearance

SQI Diagnostics' SQiDworks automated platform and IgXPLEX RA assay receive FDA marketing clearance

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Patients on immunosuppressant medication can receive H1N1 vaccine in the form of shots

Lexicon Pharmaceuticals reports fiscal 2009 third-quarter results and updates of its clinical trials

Lexicon Pharmaceuticals reports fiscal 2009 third-quarter results and updates of its clinical trials

Researchers explore link between workplace stress and exposure on GI disorders

Researchers explore link between workplace stress and exposure on GI disorders

Patients with Inflammatory Bowel Disease may be at risk for developing non-melanoma skin cancer

Patients with Inflammatory Bowel Disease may be at risk for developing non-melanoma skin cancer

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

Additional CFTR inhibitor technology licensed to Napo Pharmaceuticals

Pharmos announces results of its Phase 2b Dextofisopam trial

Pharmos announces results of its Phase 2b Dextofisopam trial

Lexicon Pharmaceuticals completes public offering of common stock shares

Lexicon Pharmaceuticals completes public offering of common stock shares